CN108840945A - Pig albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon - Google Patents

Pig albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon Download PDF

Info

Publication number
CN108840945A
CN108840945A CN201810751030.4A CN201810751030A CN108840945A CN 108840945 A CN108840945 A CN 108840945A CN 201810751030 A CN201810751030 A CN 201810751030A CN 108840945 A CN108840945 A CN 108840945A
Authority
CN
China
Prior art keywords
pig
interferon
fusion protein
gene
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810751030.4A
Other languages
Chinese (zh)
Inventor
高耀辉
鲍可兵
徐慕珍
杨建伟
付超
周炜
凡玉芳
徐文俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANHUI JIUCHUAN BIOTECHNOLOGY Co Ltd
Original Assignee
ANHUI JIUCHUAN BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANHUI JIUCHUAN BIOTECHNOLOGY Co Ltd filed Critical ANHUI JIUCHUAN BIOTECHNOLOGY Co Ltd
Publication of CN108840945A publication Critical patent/CN108840945A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/31Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention discloses pig albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method and its encoding genes, a boar long-acting interferon, pig albumin, porcine interferon alpha and porcine interleukin 2 are connected by flexibility linker, obtain pig albumin-interferon-' alpha '-interleukin-22 fusion protein, its encoding gene of design optimization, Recombinant Swine long-acting interferon is finally prepared, it is remarkably improved the half-life period of pig interferon, the half-life period of more common pig interferon improves 27 times or more, and has broad-spectrum disease resistance toxic action and can improve the immune response of pig itself.

Description

Pig albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method and its coding base Cause, a boar long-acting interferon
Technical field
The invention belongs to technical field of biological genetic engineering, and in particular to pig albumin-interferon-' alpha '-interleukin-22 merges egg White, preparation method and its encoding gene, a boar long-acting interferon.Pig albumin, porcine interferon alpha and porcine interleukin 2 are passed through Flexible flexibility linker connection, obtains pig albumin-interferon-' alpha '-interleukin-22 fusion protein, its encoding gene of design optimization, most Recombinant Swine long-acting interferon is prepared eventually.
Background technique
Scale Compact Develop is rapidly growing in China in recent years, and China's live pig breeding stock and pork production are sure to occupy First place in the world, traditional swine disease control method is far from the control for adapting to infectious disease in extensive intensive pig production production.I Newly there are nearly 20 kinds of livestock and poultry infectious diseases in the past 20 years in state, in addition original animal epidemic, causes aquaculture industry of China huge Economic loss.According to incompletely statistics, China is every year because various viral diseases cause mortality of livestock to be up to 15%-20%, Economic loss reaches billions of members.Vaccine inoculation and use are mainly passed through to the prevention and treatment approach of porcine viral diseases at present Antibiotic, but since breeding environment is not perfect, the reasons such as virus variation and Abwehrkraft des Koepers variation make traditional prevention and control Treatment approach receives huge challenge, most of antibiotics and traditional oral antiviral medicament, due to medicament residue Problem is brought a negative impact to people's health;And traditional vaccine, high specific and side effect due to it can not be resisted Virus variation and new virus, which continuously emerge, gives pig aquaculture bring significant damage.
Seralbumin is the important component of blood plasma, is not easy under normal circumstances through glomerulus, internal distributed pole it is wide and There is no zymetology and immunologic competence, is ideal pharmaceutical carrier.
IFN is that a kind of virus infection induction body generates and has broad-spectrum antiviral, antitumor and with immunoregulation effect Protein, nineteen fifty-seven Issacs and Lindeman first discovery, it is a kind of multi-functional cell factor, with cell receptor In conjunction with rear, it can induce body and generate a variety of specific proteins and enzyme, it is main by inhibiting viral gene transcription and degradation disease Malicious RNA inhibits the growth and breeding of virus and plays antitumor etc. activity.Now it is known that α type IFN in vivo can be selective Ground acts on the infection cells such as virus, by inhibiting the biosynthesis of the virus protein in infected cell, plays wide spectrum and height Imitate antivirus action.But it is faint without acting on or acting on to normal host cell.IFN-α main physiological activity is with inhibition disease Malicious duplication, anti parasitic, the killing activity for inhibiting various kinds of cell proliferation, stimulation immunocyte.
Cell factor IL-2, that is, interleukin 2 also known as t cell growth factor.Mainly produced by the T lymphocyte activated The raw cell factor with extensive bioactivity can both promote lymphopoiesis, enhance immune function, and can restricted T Cell effect and the immune tolerance for enhancing body, therefore can be used for treating tumour, infectious diseases and autoimmune disease.In beast In doctor, since IL-2 can improve the immune response of vaccine and reduce the generation of disease, also there is wide application prospect.IL-2 because The immune level that body can be enhanced improves the disease resistance of body, thus for bacillary, viral and parasitic diseases Immunization therapy.In addition, IL-2 can also influence the metabolism of drug, extend the metabolism time of drug, action time increases, to mention High curative effect of medication.IL-2 and other cell factors form fusion protein according to gene constructed, with enhance the antibody of vaccine generate and Improve cellular immune level.
The limitation of natural interferon and artificial recombination interferon generally existing half-life short at present, half-life period are generally 2-4 A hour.Half-life short brings great inconvenience, the increase for the treatment of number of times, corresponding time cost and economic cost to treatment Increase therewith, and the tenability limit of body is also possible to be broken the generation for leading to adverse reaction.The main reason for half-life short There are two:The too small tachytrophism in vivo of the molecular weight of interferon, interferon especially recombinant interferon affinity is poor to be exempted from Epidemic disease system is removed.
And common long-acting interferon is using polyethylene glycol fused interferon as representative on the market, only in the level of molecular weight Part solves the problems, such as that interferon molecule amount is small and leads to half-life short, while polyethylene glycol fused interferon cost is very Height is unfavorable for clinically applying.
Summary of the invention
In order to solve the above technical problems, the purpose of the present invention is to provide pig albumin-interferon-' alpha '-interleukin-22s to merge egg Pig albumin, porcine interferon alpha and porcine interleukin 2 are connected by flexibility flexibility linker, it is white to obtain pig by bletilla preparation method Albumen-interferon-' alpha '-interleukin-22 fusion protein.
Another object of the present invention is to provide the encoding gene of above-mentioned pig albumin-interferon-' alpha '-interleukin-22 fusion protein.
It is also an object of the present invention to provide a kind of long-acting pig interferons, utilize above-mentioned pig albumin-interferon-' alpha '- It is freeze-dried that a boar long-acting interferon, the pig is prepared after interleukin-22 fusion protein is mixed with freeze drying protectant Long-acting interferon is remarkably improved the half-life period of pig interferon, and the half-life period of more common pig interferon improves 27 times or more, and has There is broad-spectrum disease resistance toxic action and the immune response of pig itself can be improved.
The technical scheme adopted by the invention is as follows:
One boar albumin-interferon-' alpha '-interleukin-22 fusion protein, the amino acid sequence table of the fusion protein is such as Shown in 400 < of SEQUENCE LISTING, 1 >.
The present invention also provides coding pig albumin-interferon-' alpha '-interleukin-22 fusion protein gene, the core of the gene Nucleotide sequence table is denoted as genome 1 as shown in 400 < of SEQUENCE LISTING, 2 >;Or such as SEQUENCE LISTING 400 Shown in 3 > of <, it is denoted as genome 2.
The genome 1 and the equal codified fusion protein of the genome 2.Genome 2 is the nucleotides sequence to genome 1 Column optimize after as a result, when usual codon adaptation indexI CAI=1.0 be considered the gene and be in the expression system Optimal high efficient expression state, CAI value is lower to show that expression is lower in host.G/C content most ideal distribution model in gene Enclosing is 30~70%, is more than that the range will affect translation and rate of rotation efficiency in any region.Pig is found using software detection Albumin, pig-α, pig IL-2 original gene codon in Escherichia coli codon adaptation indexI (CAI) be respectively 0.24, 0.22,0.23, GC percentage is 43.7%, 59.1%, 38.7%;And by pig albumin, pig-α, pig IL-2 gene optimization After obtain each gene in Escherichia coli codon adaptation indexI (CAI) be 0.98,1.0,0.97, GC percentage 50.3%, 55.6%, 47.6%.The utilization rate of low codon is significantly reduced by gene optimization, avoids rare codon to albumen table The influence reached improves the G/C content of gene, improves transcription and translation efficiency.
The present invention also provides the expression vectors containing genome 1 or genome 2.
Further, the expression vector is the pET-32a coli expression carrier containing genome 1 or genome 2.
The present invention also provides the genetic engineering bacteriums containing genome 1 or genome 2.
Further, the genetic engineering bacterium is pET-32a/rAlb-IFN α-IL2.
Host cell containing genome 1 or genome 2 also belongs to protection scope of the present invention, further, the place Chief cell is e. coli host cell, and further, the e. coli host cell is BL21 (DE3) competent cell Or BL21 (DE3) competent cell with pGro7 plasmid.
The present invention also provides the preparation method of pig albumin-interferon-' alpha '-interleukin-22 fusion protein, the preparation methods Include the following steps:Expression vector containing genome 1 or genome 2 is imported into e. coli host cell, base is obtained Because of engineering bacteria, genetic engineering bacterium obtains the crude product of the fusion protein after IPTG inducing expression, can be obtained and melts after purified Hop protein.
Further, the expression vector is the pET-32a coli expression carrier containing genome 1 or genome 2;
Further, the genetic engineering bacterium is pET-32a/rAlb-IFN α-IL2, and preparation method is:
(1), design primer obtains by reverse transcription or is manually respectively synthesized the white egg of pig for connecting flexible linker sequence The target gene of white, porcine interferon alpha and pig interleukin 2 and 6;It is by flexible linker that pig albumin, porcine interferon alpha, pig is white The target gene of cytokine 2 connects, the nucleotides sequence list of the target gene after connection such as SEQUENCE LISTING Shown in 400 <, 2 > or as shown in 400 < of SEQUENCE LISTING, 3 >;
(2), the target gene after connection is connected on pET-32a plasmid and obtains expression vector;
(3), expression vector is imported into e. coli host cell, genetic engineering bacterium pET-32a/ can be obtained rAlb-IFNα-IL2。
Further, the e. coli host cell is for BL21 (DE3) competent cell or with pGro7 plasmid BL21 (DE3) competent cell.BL21 (DE3) competent cell with pGro7 plasmid has purchased from Shanghai offshore science and technology Limit company/glad hundred promise biology, article No. V205.
Further, the method for the purifying is:The crude product of fusion protein is successively through affinity chromatography, anion-exchange chromatography And molecular sieve chromatography purification.
Further, the acquisition methods of the genome 1 are:
A. design of primers
The primer sequence of pig albumin (Alb) is:
Upstream Alb-F1:
CATGCCATGGTGACACCTACAAATCTG has NcoI restriction enzyme site;
Downstream Alb-R1:
ACCACCACCAGAACCACCACCACCAGCCAGGATACCACG, with flexible linker;
The primer sequence of porcine interferon alpha (IFN-α) is:
Upstream-α-F1:
GGTGGTTCTGGTGGTGGTGGTTCTTGCGACCTGCCTCAGAC, with flexible linker;
Downstream-α-R1:
ACCACCACCAGAACCACCACCACCCTCCTTCTTCCTGAGTCTGT, with flexible linker;
The primer sequence of pig interleukin 2 and 6 (IL-2) is:
Upstream IL-2-F1:
GGTGGTTCTGGTGGTGGTGGTTCTATGTATAAGATGCAGCTCTTGC, with flexible linker;
Downstream IL-2-R1:CCCTCGAGAGTCAGTGTTGAGTAGATGCTT has XhoI restriction enzyme site;
B. RNA is extracted from pig liver, by reverse transcription obtain pig Alb, pig IFN-α and pig IL-2 target gene, three The gene order of person respectively as shown in 400 < of SEQUENCE LISTING, 4 >, 400 < of SEQUENCE LISTING, 5 > and Shown in 400 < of SEQUENCE LISTING, 6 >;
Respectively using the target gene of pig Alb, pig IFN-α and pig IL-2 as template, and be utilized respectively pig Alb, pig IFN-α and The upstream and downstream primer of pig IL-2 carries out PCR amplification.
PCR reaction system and condition are:In the overall reaction system of 25 μ L, 1.5 μ L of geneome RNA, upstream and downstream primer is each 0.5 μ L, 2.5 μ L, dNTP Mix of reverse transcriptase are 10 μ L, add RNase Free water to 25 μ L;The reaction of the RT-PCR reaction Condition is:50 DEG C of reverse transcriptions 30min, 95 DEG C of initial denaturation 4min, into circulation;95 DEG C of denaturation 45s, 58 DEG C of annealing 45s, 72 DEG C are prolonged 1kb/min is stretched, is recycled 35 times, last 72 DEG C of extensions 10min.
C. flexibility linker connection pig Alb and Po IFNα gene are utilized, Alb-IFN α gene is obtained:
The PCR reaction system and reaction condition of connection be:In the overall reaction system of 25 μ L, connect flexible linker's 1 μ L of Alb gene template DNA connects 1 μ L, Alb upstream primer of IFN-α template DNA, the 0.5 μ L of flexible linker, IFN-α 0.5 μ L, Taq DNA polymerase of downstream primer, 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;Connect PCR Reaction condition is:95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, altogether 35 circulations;Last 72 DEG C of extensions 10min.
D. flexibility linker connection Alb-IFN α gene and pig IL2 gene are utilized, rAlb-IFN α-IL2 gene is obtained:
The PCR reaction system and reaction condition of connection be:In the overall reaction system of 25 μ L, Alb-IFN α gene template 1 μ L of DNA connects 1 μ L, Alb upstream primer of IL-2 template DNA, 0.5 μ L, IL-2 downstream primer, the 0.5 μ L of flexible linker, 2.5 μ L, dNTP Mix of Taq archaeal dna polymerase is 10 μ L, adds RNase Free water to 25 μ L;Connecting PCR reaction condition is:95 DEG C initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, totally 35 recycle;Finally 72 DEG C of extension 10min.
Genome 2 is artificial synthesized gene after optimizing to genome 1, the acquisition methods of the genome 2 For:
A. design of primers
The primer sequence of pig albumin (Alb) is:
Upstream Alb-F2:CATGCCATGGTGACACCTACAAATCTG has NcoI restriction enzyme site;
Downstream Alb-R2:
ACCACCACCAGAACCACCACCACCAGCCAGGATACCACG, with flexible linker;
The primer sequence of porcine interferon alpha (IFN-α) is:
Upstream-α-F2:
GGTGGTTCTGGTGGTGGTGGTTCTATGTGCTCTTACCTG, with flexible linker;
Downstream-α-R2:
ACCACCACCAGAACCACCACCACCTTCTTTACGACGCAG, with flexible linker;
Pig interleukin 2 and 6 (IL-2):
Upstream IL-2-F2:
GGTGGTTCTGGTGGTGGTGGTTCTATGTACAAAATGCAGC, with flexible linker;
Downstream IL-2-R2:
CCCTCGAGGGTCAGGGTAGAGTAG has XhoI restriction enzyme site.
B. the pig Alb, pig IFN-α and pig IL-2 target gene, the gene order of three is respectively such as SEQUENCE Shown in 400 < of LISTING, 7 >, 400 < of SEQUENCE LISTING 400 <, 8 > and SEQUENCE LISTING, 9 >;
Respectively using the target gene of pig Alb, pig IFN-α and pig IL-2 as template, and be utilized respectively pig Alb, pig IFN-α and The upstream and downstream primer of pig IL-2 carries out PCR amplification.
PCR reaction system and condition are:In the overall reaction system of 25 μ L, 1 μ L of genomic DNA, upstream and downstream primer is each 0.5 μ L, Taq DNA polymerase, dNTP Mix are 10 μ L, add RNase Free water to 25 μ L;The reaction of the RT-PCR reaction Condition is:95 DEG C of 4 min of initial denaturation, into circulation;95 DEG C of denaturation 45s, 60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, circulation 35 times, last 72 DEG C of extensions 10min.
C. flexibility linker connection pig Alb and Po IFNα gene are utilized, Alb-IFN α gene is obtained:
The PCR reaction system and reaction condition of connection be:In the overall reaction system of 25 μ L, connect flexible linker's 1 μ L of Alb gene template DNA connects 1 μ L, Alb upstream primer of IFN-α template DNA, the 0.5 μ L of flexible linker, IFN-α 0.5 μ L, Taq DNA polymerase of downstream primer, 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;Connect PCR Reaction condition is:95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, altogether 35 circulations;Last 72 DEG C of extensions 10min.
D. flexibility linker connection Alb-IFN α gene and pig IL2 gene are utilized, rAlb-IFN α-IL2 gene is obtained:
The PCR reaction system and reaction condition of connection be:In the overall reaction system of 25 μ L, Alb-IFN α gene template 1 μ L of DNA connects 1 μ L, Alb upstream primer of IL-2 template DNA, 0.5 μ L, IL-2 downstream primer, the 0.5 μ L of flexible linker, 2.5 μ L, dNTP Mix of Taq archaeal dna polymerase is 10 μ L, adds RNase Free water to 25 μ L;Connecting PCR reaction condition is:95 DEG C initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, totally 35 recycle;Finally 72 DEG C of extension 10min.
The present invention also provides a boar long-acting interferon, the pig long-acting interferon is by the pig albumin-interference It is freeze-dried to form after plain α-interleukin-22 fusion protein and freeze drying protectant mixture.
The freeze drying protectant is glycerol, mannitol and sucrose, is buffer, the final concentration of three with 10mmol/L PBS For glycerol 100mL/L, mannitol 0.12g/mL and sucrose 0.025g/mL.
The present invention also provides the application of the pig long-acting interferon, long half time had wide spectrum up to 109 hours or more Antivirus action and the immune response that pig itself can be improved.
Compared with prior art, the present invention has the advantages that:
1. pig Alb, pig IFN-α and pig IL-2 gene are realized amalgamation and expression by flexibility linker, interferon is improved Half-life period improves 27 times compared with plain interferon;Compared with common polyethylene glycol fused interferon, significantly reduce into This.
2. improving pig Alb, pig IFN-α and pig IL-2 by optimizing to pig Alb, pig IFN-α and pig IL-2 gene The expression quantity of fusion protein.
3. using recombination bacillus coli pET-32a/Alb- α-IL2 as expression bacterial strain, by introducing molecular chaperones pGro7 matter Grain, in protein expression, generation inclusion body is less, forms great amount of soluble albumen, avoids the mistake of inclusion body denaturation and renaturation Journey substantially reduces the time of expressing fusion protein;
4. the fusion protein disclosed by the invention being made of pig Alb, pig IFN-α and pig IL-2 not only has the wide of IFN-α Antivirus action is composed, while significantly improving the immune response of pig itself.
Detailed description of the invention
Fig. 1 is that pig albumin gene, porcine interferon alpha gene and the pig interleukin 2 and 6 gene RT-PCR in embodiment 1 expand The result of increasing;Swimming lane M:DNA Marker DL2000;Swimming lane 1:2 gene RT-PCR amplified production of porcine interleukin;Swimming lane 2:Pig is dry Disturb plain α gene RT-PCR amplified production;Swimming lane 3:Pig albumin gene RT-PCR amplified production;
Fig. 2 be embodiment 1 in pig Alb, IFN-α connected with the target gene of IL-2 after PCR amplification result;Swimming Road M:DNA Marker DL10000;Swimming lane 1:Pig albumin gene, porcine interferon alpha gene connect expansion with 2 gene of porcine interleukin Increase production object;
Fig. 3 is the PCR amplification and double digestion qualification result of the positive colony plasmid in embodiment 1;Swimming lane M:DNA Marker DL10000;Swimming lane 1:Recombinant plasmid double digestion result;Swimming lane 2:Plasmid PCR result;
Fig. 4 is the SDS-PAGE electrophoretic examinations result of the recombinant protein in embodiment 1;Swimming lane M:Albumen Marker;Swimming lane 1:Supernatant after bacterial cell disruption after recombinant bacterium induction;Swimming lane 2:It is precipitated after bacterial cell disruption after recombinant bacterium induction;Swimming lane 3:It is unloaded Control;
Fig. 5 is the Western Blot qualification result for the fusion protein that embodiment 1 obtains;Swimming lane M:Albumen Marker;Swimming Road 1:It is precipitated after recombinant bacterium induction is broken;Swimming lane 2:For the broken rear supernatant of recombinant bacterium induction;
Fig. 6 is that the Recombinant Swine long-acting interferon α as made from the fusion protein in embodiment 1 causes cell to VSV in embodiment 5 The inhibiting effect of lesion;1 is VSV virus control wells;2 be HEp-2 cell control well;A3-12 is gradient dilution (from right to left) Human interferon standard items handle hole;B3-12 is that the recombinant long-acting porcine interferon alpha of gradient dilution (from right to left) handles hole;
Fig. 7 is the Recombinant Swine long-acting interferon α intramuscular injection blood as made from the fusion protein in embodiment 1 in embodiment 8 Concentration-time changing curve.
Specific embodiment
Embodiment 1
The preparation method of pig albumin-interferon-' alpha '-interleukin-22 fusion protein, includes the following steps:
1. the acquisition of pig albumin (Alb), porcine interferon alpha (IFN-α) and pig interleukin 2 and 6 (IL-2) target gene with Amplification
Design of primers:
Synthetic primer is designed according to objective gene sequence reported in Genebank and is shown in Table 1, in the upstream of pig albumin In primer introduce EcoRI restriction enzyme site, in downstream primer introduce Linker sequence, porcine interferon alpha upstream primer and under Linker sequence is introduced respectively in trip primer, Linker sequence is introduced in the upstream primer of pig interleukin 2 and 6, in downstream primer Middle introducing SalI restriction enzyme site.
1 PCR amplification primer of table
RT-PCR obtains target gene:
RNA is extracted from pig liver tissue, and the target gene of pig Alb, pig IFN-α and pig IL-2 are obtained by reverse transcription, The gene order of three is respectively such as 400 < of SEQUENCE LISTING, 4 >, 400 < of SEQUENCE LISTING, 5 > and SEQUENCE Shown in 400 < of LISTING, 6 >;
RT-PCR reaction system (25 μ L) is shown in Table 2
2 RT-PCR reaction system of table
Response parameter is:50 DEG C of reverse transcriptions 30min, 95 DEG C of initial denaturation 4min, into circulation:95 DEG C of denaturation 45s;58 DEG C are moved back Fiery 45s, 72 DEG C of extension 1kb/min, totally 35 recycle;Last 72 DEG C of extensions 10min.
There is specific band in 1780bp, 740bp and 490bp or so through agarose gel electrophoresis in RT-PCR amplified production, Its result illustrates the target gene that pig Alb, pig IFN-α and pig IL-2 has been prepared as shown in Fig. 1.
2. the connection of target gene
Target gene is diluted to 10ug/mL, connects each section of target gene using over-lap PCR, 25 μ L reaction systems are such as Shown in table 3, table 4:
3 Alb-IFN- α PCR reaction system of table
4 Alb-IFN- α-IL-2 PCR reaction system of table
Response parameter is:95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extensions 1kb/min, totally 35 recycle;Last 72 DEG C of extensions 10min.
There is specific band in 2950bp or so through agarose gel electrophoresis in pcr amplification product, result as shown in Fig. 2, Occurs Alb-IFN α and IL-2 amplified product band in Fig. 2, this is because the process connected in Alb-IFN α with IL-2 gene In, there is non-specific responding.The nucleotide sequence of obtained target gene is as shown in 400 < of SEQUENCE LISTING, 2 >.
3. expression vector establishment
For target gene after selection connection after sequencing is errorless, PCR glue recovery product and pET-32a plasmid use NcoI Double digestion and recycling are carried out with XhoI restriction enzyme, does double digestion by 20 μ L systems in table 5:
5 double digestion system of table
General buffer 2μL
Restriction enzyme (a pair) 1μL+1μL
Carrier or recycling segment 2ul
RNase Free water 14μL
The digestion recovery product of target gene and pET-32a plasmid after connection is attached by the system in table 6,4 DEG C overnight connection:
6 enzyme disjunctor system of table
Target fragment DNA 10μL
Expression vector 3μL
buffer 2μL
Ligase 1μL
RNase Free water 4μL
Connection product is converted into e. coli bl21 (DE3) competent cell, competent cell is coated on benzyl containing ammonia The LB culture medium flat plate of penicillin is incubated overnight;Single colonie on picking LB plate carries out target gene PCR identification, positive colony Bacteria plasmid identifies that being accredited as positive indicates that engineering bacteria constructs successfully, and PCR amplification and double digestion are produced through NcoI and XhoI double digestion Object detects single band through agarose gel electrophoresis at 2950bp, and result is as shown in Figure 3.
4. the expression of recombinant protein
Picking engineering bacteria 37 DEG C of shaking table recovery 1h, engineering bacteria in the LB culture medium containing 100 μ g/ml ampicillins are denoted as pET-32a/rAlb-IFNα-IL2;Amplification culture 4h (OD ≈ 1.0) in LB culture medium (the 100 μ g/ml containing ampicillin), Final concentration 100 μ g/ml IPTG, 32 DEG C of inducing expression 5h is added;Thallus is collected, through SDS-PAGE electrophoresis detection, result is such as Shown in Fig. 4, it can be seen from the figure that recombinant bacterium induction 5h after bacterial cell disruption after supernatant be deposited in the place 126.4KD or so can See predominant expression band, illustrates in precipitating and successful expression equal in supernatant fusion protein.
Mass volume ratio 1 is added:Precipitating is resuspended in 1 PBS;- 20 DEG C precipitate 3 times in room temperature multigelation;4 DEG C of ultrasound cracking Bacterial precipitation, work 10s, is spaced 3S, ultrasonic 6min, and whole process repeats 3~4 times;4 DEG C, 12000r/min is centrifuged 15min, Supernatant, inclusion body (inclusion body is through dissolution, refolding strategy) are taken respectively, obtain crude fusion protein.
5. fusion protein purification
5.1 His affinity chromatographys
After membrane filtration of the crude fusion protein with 0.22 μm of aperture, loading is by being connected to AKTA explorer 100 On protein purification system, the His affinity column balanced with Binding Buffer I (PBS) is washed away not with PBS buffer solution In conjunction with albumen, until A280nm stablize, then with Elution buffer I (50mM trishydroxymethylaminomethane, 20~ 500mM imidazoles, PH8.0) elution, collect rAlb-IFN α-IL2 protein peak.
5.2 DEAE anion-exchange chromatographies
By the albumen collected after His affinitive layer purification displacement to (the 50mM trihydroxy methyl of Binding Buffer II Aminomethane, PH6.5) in after, loading by the DEAE anion exchange chromatography that has been balanced with Binding Buffer II, After being stablized again with the column of Binding Buffer II to A280nm value, with (the 50mM trihydroxy methyl ammonia of Elution Buffer II Methylmethane, 1M NaCl, PH6.5) linear gradient elution, collect rAlb-IFN α-IL2 protein peak.
5.3 sieve chromatography
Loading is by with III (50mM of Binding Buffer after the sample concentration that ion-exchange chromatography is collected into Na2HPO4,0.15M NaCl, PH7.4) 200 molecular sieve chromatography of Superdex has been balanced, it is washed with Binding Buffer III It is de-, collect rAlb-IFN α-IL2 protein peak.
5.4 sample identification
Measure rAlb-IFN α-IL2 potency and specific activity, specific activity >=105U/mg, albumen are qualified;It is aseptic subpackaged, -80 DEG C It saves.The fusion protein being made of pig albumin, porcine interferon alpha and pig interleukin 2 and 6 can be obtained, amino acid sequence is such as Shown in 400 < of SEQUENCE LISTING, 1 >.
Pig albumin-interferon-' alpha '-interleukin-22 fusion protein is prepared using the above method.
Embodiment 2
The preparation method of one boar albumin-interferon-' alpha '-interleukin-22 fusion protein, the preparation method is the same as that of Example 1, only E. coli bl21 therein (DE3) competent cell is replaced in order to which BL21 (DE3) competence with pGro7 plasmid is thin Born of the same parents.The SDS-PAGE electrophoresis result of its fusion protein is compareed with embodiment 1,126.4KD or so place's predominant expression item in supernatant Band is thicker, illustrates after introducing molecular chaperones pGro7, expression of the destination protein in supernatant is more preferable, obtained fusion protein amount It is higher.The albumen of Bacillus coli expression is mostly present in inclusion body;By introducing molecular chaperones in expression bacterial strain, cooperate with Expression albumen correctly folds, and reaches solubility expression of protein.
BL21 (DE3) competent cell with pGro7 plasmid is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise Biology, article No. V205.
Pig albumin-interferon-' alpha '-interleukin-22 fusion protein is prepared using the above method.
Embodiment 3
The preparation method of one boar albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method are as follows:
1. the acquisition of pig albumin (Alb), porcine interferon alpha (IFN-α) and pig interleukin 2 and 6 (IL-2) target gene with Amplification
Pig Alb, pig IFN-α and pig IL-2 in embodiment 1 is optimized, artificially synthesized pig Alb, pig IFN-α and pig IL-2 target gene, after optimization, the nucleotide sequence of three is respectively such as 400 < of SEQUENCE LISTING 7 >, SEQUENCE Shown in 400 < of LISTING 400 <, 8 > and SEQUENCE LISTING, 9 >.
1.1 codon optimization
Genetic codon has 64 kinds, but most biological tendencies are in utilizing a part in these codons.Those By the most frequent referred to as best codon (optimal codons) utilized, what those were not frequently utilized that is known as rare or utilizes The low codon of rate (rare or low-usage codons).In fact, common every kind of biology for doing protein expression or production (including Escherichia coli, yeast, mammalian cell, plant cell and insect cell) all shows the benefit of codon to a certain degree Difference or preference.The expression efficiency of the gene containing best codon is apparently higher than in Escherichia coli, yeast and drosophila and is contained The expression efficiency of the gene of the codon of poor efficiency.Therefore, in heterologous expression system, the preferences of codon are largely On affect the expression of recombinant protein.Using preference codon (preferred codons) and avoid utilizing rare codon Gene chemical synthesis is carried out, the redesign of this gene is codon optimization.Therefore, the pig Alb in the present embodiment couple, pig IFN-α It is optimized with pig IL-2 gene codon.
Interpretation of result after 1.2 codon optimizations
It is optimal efficient in the expression system to be considered the gene when usual codon adaptation indexI (CAI)=1.0 Expression status, CAI value is lower to show that expression is lower in host.In gene G/C content most ideal distribution range be 30~ 70%, it is more than that the range will affect translation and rate of rotation efficiency in any region.Using software detection discovery pig albumin, Pig-α, pig IL-2 original gene codon in Escherichia coli codon adaptation indexI (CAI) be respectively 0.24,0.22, 0.23, GC percentage is 43.7%, 59.1%, 38.7%;And by being obtained to after pig albumin, pig-α, pig IL-2 gene optimization To each gene in Escherichia coli codon adaptation indexI (CAI) be 0.98,1.0,0.97, GC percentage 50.3%, 55.6%, 47.6%.The utilization rate of low codon is significantly reduced by gene optimization, avoids rare codon to the shadow of protein expression It rings, improves the G/C content of gene, improve transcription and translation efficiency, and then improve the expression quantity of recombinant protein.
1.3 design of primers:
7 PCR amplification primer of table
The genomic DNA of pig Alb, pig IFN-α and pig IL-2 after optimization are diluted to 0.05mg/mL respectively.Utilize PCR Amplification obtains target gene, and 25 μ L reaction systems are as shown in table 8:
8 PCR reaction system of table
RNase Free water 10.5μL
dNTP Mix 10.0μL
Taq archaeal dna polymerase 2.5μL
Upstream and downstream primer Each 0.5 μ L
Genomic DNA 1.0μL
Response parameter is:95 DEG C of initial denaturation 4min, into circulation:95 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extensions 1kb/min, totally 35 recycle;Last 72 DEG C of extensions 10min.
The pcr amplification product of pig Alb, pig IFN-α and pig IL-2 are through agarose gel electrophoresis respectively in 1780bp, 740bp There is specific band with 490bp or so, the purpose base of pig Alb, pig IFN-α and pig IL-2 after illustrating to be prepared optimization Cause.
2. the connection of target gene
Target gene is diluted to 10ug/mL, connects each section of target gene using over-lap PCR, 25 μ L reaction systems are such as Shown in table 9, table 10:
9 Alb-IFN α PCR reaction system of table
10 rAlb-IFN α-IL2 PCR reaction system of table
Response parameter is:95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extensions 1kb/min, totally 35 recycle;Last 72 DEG C of extensions 10min.
There is specific band in 2950bp or so through agarose gel electrophoresis in pcr amplification product, is Alb-IFN α and IL-2 Amplified product band, this is because there is non-specific responding during Alb-IFN α is connected with IL-2 gene.It obtains The nucleotide sequence of target gene is as shown in 400 < of SEQUENCE LISTING, 3 >.
3. expression vector establishment
The glue recovery product for the PCR for selecting the target gene after connecting errorless after being sequenced is used with pET-32a plasmid NcoI, XhoI restriction enzyme carry out double digestion and recycling, do double digestion by 20 μ L systems in table 11:
11 double digestion system of table
General buffer 2μL
Restriction enzyme (a pair) 1μL+1μL
Carrier or recycling segment 2ul
RNase Free water 14μL
The digestion recovery product of target gene and pET-32a plasmid after connection is attached by the system in table 12,4 DEG C overnight connection:
Table 12
Connection product is converted into e. coli bl21 (DE3) competent cell, competence is coated on the mould of benzyl containing ammonia It is incubated overnight in the LB plate of element;The bacterium colony grown on LB plate is taken to identify target gene, positive colony bacteria plasmid warp through PCR The identification of NcoI, XhoI double digestion, being accredited as positive indicates expression vector establishment success, and PCR amplification and double enzyme digestion product are through fine jade There is single band at the place 2950bp or so in sepharose electrophoresis, illustrates that the expression containing rAlb-IFN α-IL2 fusion carries Body constructs successfully.
4. the expression of recombinant protein
Picking engineering bacteria 37 DEG C of shaking table recovery 1h, engineering bacteria in the LB culture medium containing 100 μ g/ml ampicillins are denoted as pET-32a/rAlb-IFNα-IL2;Amplification culture 4h (OD ≈ 1.0) in LB culture medium (the 100 μ g/ml containing ampicillin), Final concentration 100 μ g/ml IPTG, 32 DEG C of inducing expression 5h is added;Thallus is collected, through SDS-PAGE electrophoresis detection, recombinant bacterium induction Supernatant is deposited in the visible predominant expression band in the place 126.4KD or so after bacterial cell disruption after 5h, illustrates in supernatant precipitating Recombinant protein is obtained.
Mass volume ratio 1 is added:Precipitating is resuspended in 1 PBS;- 20 DEG C precipitate 3 times in room temperature multigelation;4 DEG C of ultrasound cracking Bacterial precipitation, work 10s, is spaced 3S, ultrasonic 6min, and whole process repeats 3~4 times;4 DEG C, 12000r/min is centrifuged 15min, Supernatant, inclusion body (inclusion body is through dissolution, refolding strategy) are taken respectively, obtain crude fusion protein.
5. fusion protein purification
5.1 His affinity chromatographys
After membrane filtration of the crude fusion protein with 0.22 μm of aperture, loading is by being connected to AKTA explorer 100 On protein purification system, the His affinity column balanced with Binding Buffer I (PBS) is washed away not with PBS buffer solution In conjunction with albumen, until A280nm stablize, then with Elution buffer I (50mM trishydroxymethylaminomethane, 20~ 500mM imidazoles, PH8.0) elution, collect rAlb-IFN α-IL2 protein peak.
5.2 DEAE anion-exchange chromatographies
By the albumen collected after His affinitive layer purification displacement to (the 50mM trihydroxy methyl of Binding Buffer II Aminomethane, PH6.5) in after, loading by the DEAE anion exchange chromatography that has been balanced with Binding Buffer II, After being stablized again with the column of Binding Buffer II to A280nm value, with (the 50mM trihydroxy methyl ammonia of Elution Buffer II Methylmethane, 1M NaCl, PH6.5) linear gradient elution, collect rAlb-IFN α-IL2 protein peak.
5.3 sieve chromatography
Loading is by with Binding Buffer III after the sample concentration that ion-exchange chromatography is collected into (50mMNa2HPO4,0.15M NaCl, PH7.4) 200 molecular sieve chromatography of Superdex has been balanced, use Binding Buffer III is eluted, and collects rAlb-IFN α-IL2 protein peak.
5.4 sample identification
Measure rAlb-IFN α-IL2 potency and specific activity, specific activity >=105U/mg, albumen are qualification;It is aseptic subpackaged, -80 DEG C save.The fusion protein being made of pig albumin, porcine interferon alpha and pig interleukin 2 and 6, amino acid sequence can be obtained As shown in 400 < of SEQUENCE LISTING, 1 >.
Pig albumin-interferon-' alpha '-interleukin-22 fusion protein is prepared using the above method.
Embodiment 4
The preparation method of one boar albumin-interferon-' alpha '-interleukin-22 fusion protein, other are with embodiment 3, only by it In e. coli bl21 (DE3) competent cell replacement in order to have pGro7 plasmid BL21 (DE3) competent cell.Its The SDS-PAGE electrophoresis result of fusion protein is compareed with embodiment 3, in supernatant 126.4KD or so place's predominant expression band compared with Slightly, illustrate after introducing molecular chaperones pGro7, expression of the destination protein in supernatant is more preferable, and obtained fusion protein amount is higher. The albumen of Bacillus coli expression is mostly present in inclusion body;By introducing molecular chaperones, coordinate expression in expression bacterial strain Albumen correctly folds, and reaches solubility expression of protein.
BL21 (DE3) competent cell with pGro7 plasmid is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise Biology, article No. V205.
Pig albumin-interferon-' alpha '-interleukin-22 fusion protein is prepared using the above method.
Embodiment 5
One boar long-acting interferon, by the fusion protein in embodiment 1,2,3,4 respectively and after freeze drying protectant mixture, It is freeze-dried to form.The freeze drying protectant is glycerol, mannitol and sucrose, is buffer, three with 10mmol/L PBS Final concentration of glycerol 100mL/L, mannitol 0.12g/mL and sucrose 0.025g/mL.
Embodiment 6
The identification for the pig albumin-interferon-' alpha '-interleukin-22 fusion protein that Examples 1 to 4 obtains
The quantitative detection of 6.1 protein contents
With Lowry method, standard test is made with the standard protein of Chinese food pharmaceutical biological product calibrating institute, measures embodiment 1~4 obtained fusion protein concentration difference 2.5mg/ml, 2.4mg/ml, 2.6mg/ml, 2.6mg/ml.
6.2SDS-PAGE electrophoresis detection
Compared with empty bacterium, fusion protein has the newly-increased protein band of a dense dye in 126.4KD or so, as shown in Figure 4.
6.3Western Blot result
Fusion protein in Examples 1 to 4 is detected, respectively with the anti-porcine alpha-IFN (1 of abcam company mouse:5000 dilutions) it is one It is anti-, using goat anti-mouse IgG-HRP as secondary antibody (1:10000 dilutions).Recombinant long-acting pig interferon sample can be with anti-porcine interferon alpha Specific reaction occurs for monoclonal antibody, and specific band occurs in the place 126.4KD or so, as shown in Figure 5.
Embodiment 7
The freeze-dried bioactivity of four parts of long-acting pig interferons of pig in embodiment 5
Inhibit method according to few cells lesion, Hep-2 cell is made into 5 × 10 with culture medium5Cell/ml cell suspends Liquid, every hole inoculation 0.1ml move into 96 porocyte culture plates.37 DEG C, 5%CO2For 24 hours, the recombinant long-acting of various dose is added in culture Pig interferon is inhaled afterwards abandon for 24 hours, then inoculation 100TCID50VSV virus respectively.
Test result
The result shows that the recombinant long-acting pig interferon obtained causes the lesion of HEp-2 cell to have apparent inhibit VSV Effect.The lesions such as there is cell rounding, falls off, is disintegrated after untreated cell inoculation virus.And the recombinant long-acting obtained After pig interferon treated cell inoculation virus, it is observed continuously under inverted microscope, cellular morphology is normal, does not occur any Lesion measures potency >=105U/ml, as shown in Figure 6.
Embodiment 8
The four parts of recombinant long-acting pig interferons obtained respectively by the fusion protein of Examples 1 to 4 in embodiment 5 are freeze-dried The measurement of (being denoted as A, B, C, D respectively) in pig intracorporal half-life period
A be embodiment 1 prepare freeze-dried, B be embodiment 2 prepare freeze-dried, C be embodiment 3 prepare it is freeze-dried, D is the freeze-dried of the preparation of embodiment 4.
The blood concentration and time relationship of cytopathic-effect inhibition assay measurement rAlb-IFN α-IL2
The pork pig (half male and half female) that six weight are roughly the same is taken, 2mg/ml Recombinant Swine long-acting interferon is subcutaneously injected in neck The freeze-dried 2ml of α, respectively in 1h, 2h, 4h, 8h, 16h, 26h, 44h, 79h venous blood collection, 4 DEG C of blood sample solidifications, 3500rpm low temperature It is centrifuged 10min and separates serum, every pig blood sample of each time point is to be measured in -20 DEG C of preservations.Serum is measured using cytopathic-effect inhibition assay The concentration of rAlb-IFN α-IL2 in sample is carried out curve fitting and calculating parameter with DAS pharmacokinetics software.Parameter calculated result It is shown in Table 13.
Dominant dynamic parameters in serum after 13 recombinant long-acting porcine interferon alpha intramuscular injection of table
The result shows that recombinant long-acting pig interferon has longer half-life period.Half-life period can reach 109h or so after measured, compared with Plain interferon improves about 27 times.
Embodiment 9
The freeze-dried measurement that pig cell immune response is influenced of four parts of recombinant long-acting pig interferons in embodiment 5
It takes six roughly the same pork pigs of weight to be divided into two groups, is denoted as experimental group and control group;Experimental group neck is subcutaneously infused The 2mg/ml freeze-dried 2ml of recombinant long-acting pig interferon is penetrated, the PBS of 2mL is subcutaneously injected in control group neck, after taking injection 4 weeks outside pig All blood takes weekly a blood later, separates lymphocyte using lymphocyte separation medium, lymphocyte passes through serum-free RPMI It after 1640 culture mediums wash 2 times, is resuspended with complete medium, adjustment cell concentration is 2 × 106A/ml, 24 porocyte culture plates are every Hole addition 1ml lymphocyte, 37 DEG C, 5%CO272h is cultivated, supernatant when collecting lymphocyte culture.ELISA detects culture supernatant Middle IFN γ, IL-4 content, are carried out by kit specification, and testing result is as shown in table 14:
It is horizontal that 14 ELISA of table detects each group pig cell immune response
The result shows that injection recombinant long-acting pig interferon after, can significantly improve cell factor IFN γ in pig peripheral blood, The content of IL-4 enhances cellullar immunologic response level, significantly improves immunity level.
It is above-mentioned that one boar albumin-interferon-' alpha '-interleukin-22 fusion protein and preparation method thereof is carried out referring to embodiment Detailed description, be illustrative without being restrictive, can enumerate several embodiments according to limited range, thus The change and modification under present general inventive concept are not departed from, should be belonged within protection scope of the present invention.
SEQUENCE LISTING
<110>Anhui Jiuchuan Biotechnology Co., Ltd.
<120>Pig albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method and its encoding gene, a boar are long-acting dry Disturb element
<130> 1
<160> 9
<170> PatentIn version 3.3
<210> 1
<211> 983
<212> PRT
<213>Fusion protein
<400> 1
Asp Thr Tyr Lys Ser Glu Ile Ala His Arg Phe Lys Asp Leu Gly Glu
1 5 10 15
Gln Tyr Phe Lys Gly Leu Val Leu Ile Ala Phe Ser Gln His Leu Gln
20 25 30
Gln Cys Pro Tyr Glu Glu His Val Lys Leu Val Arg Glu Val Thr Glu
35 40 45
Phe Ala Lys Thr Cys Val Ala Asp Glu Ser Ala Glu Asn Cys Asp Lys
50 55 60
Ser Ile His Thr Leu Phe Gly Asp Lys Leu Cys Ala Ile Pro Ser Leu
65 70 75 80
Arg Glu His Tyr Gly Asp Leu Ala Asp Cys Cys Glu Lys Glu Glu Pro
85 90 95
Glu Arg Asn Glu Cys Phe Leu Gln His Lys Asn Asp Asn Pro Asp Ile
100 105 110
Pro Lys Leu Lys Pro Asp Pro Val Ala Leu Cys Ala Asp Phe Gln Glu
115 120 125
Asp Glu Gln Lys Phe Trp Gly Lys Tyr Leu Tyr Glu Ile Ala Arg Arg
130 135 140
His Pro Tyr Phe Tyr Ala Pro Glu Leu Leu Tyr Tyr Ala Ile Ile Tyr
145 150 155 160
Lys Asp Val Phe Ser Glu Cys Cys Gln Ala Ala Asp Lys Ala Ala Cys
165 170 175
Leu Leu Pro Lys Ile Glu His Leu Arg Glu Lys Val Leu Thr Ser Ala
180 185 190
Ala Lys Gln Arg Leu Lys Cys Ala Ser Ile Gln Lys Phe Gly Glu Arg
195 200 205
Ala Phe Lys Ala Trp Ser Leu Ala Arg Leu Ser Gln Arg Phe Pro Lys
210 215 220
Ala Asp Phe Thr Glu Ile Ser Lys Ile Val Thr Asp Leu Ala Lys Val
225 230 235 240
His Lys Glu Cys Cys His Gly Asp Leu Leu Glu Cys Ala Asp Asp Arg
245 250 255
Ala Asp Leu Ala Lys Tyr Ile Cys Glu Asn Gln Asp Thr Ile Ser Thr
260 265 270
Lys Leu Lys Glu Cys Cys Asp Lys Pro Leu Leu Glu Lys Ser His Cys
275 280 285
Ile Ala Glu Ala Lys Arg Asp Glu Leu Pro Ala Asp Leu Asn Pro Leu
290 295 300
Glu His Asp Phe Val Glu Asp Lys Glu Val Cys Lys Asn Tyr Lys Glu
305 310 315 320
Ala Lys His Val Phe Leu Gly Thr Phe Leu Tyr Glu Tyr Ser Arg Arg
325 330 335
His Pro Asp Tyr Ser Val Ser Leu Leu Leu Arg Ile Ala Lys Ile Tyr
340 345 350
Glu Ala Thr Leu Glu Asp Cys Cys Ala Lys Glu Asp Pro Pro Ala Cys
355 360 365
Tyr Ala Thr Val Phe Asp Lys Phe Gln Pro Leu Val Asp Glu Pro Lys
370 375 380
Asn Leu Ile Lys Gln Asn Cys Glu Leu Phe Glu Lys Leu Gly Glu Tyr
385 390 395 400
Gly Phe Gln Asn Ala Leu Ile Val Arg Tyr Thr Lys Lys Val Pro Gln
405 410 415
Val Ser Thr Pro Thr Leu Val Glu Val Ala Arg Lys Leu Gly Leu Val
420 425 430
Gly Ser Arg Cys Cys Lys Arg Pro Glu Glu Glu Arg Leu Ser Cys Ala
435 440 445
Glu Asp Tyr Leu Ser Leu Val Leu Asn Arg Leu Cys Val Leu His Glu
450 455 460
Lys Thr Pro Val Ser Glu Lys Val Thr Lys Cys Cys Thr Glu Ser Leu
465 470 475 480
Val Asn Arg Arg Pro Cys Phe Ser Ala Leu Thr Pro Asp Glu Thr Tyr
485 490 495
Lys Pro Lys Glu Phe Val Glu Gly Thr Phe Thr Phe His Ala Asp Leu
500 505 510
Cys Thr Leu Pro Glu Asp Glu Lys Gln Ile Lys Lys Gln Thr Ala Leu
515 520 525
Val Glu Leu Leu Lys His Lys Pro His Ala Thr Glu Glu Gln Leu Arg
530 535 540
Thr Val Leu Gly Asn Phe Ala Ala Phe Val Gln Lys Cys Cys Ala Ala
545 550 555 560
Pro Asp His Glu Ala Cys Phe Ala Val Glu Gly Pro Lys Phe Val Ile
565 570 575
Glu Ile Arg Gly Ile Leu Ala Gly Gly Gly Gly Ser Gly Gly Gly Gly
580 585 590
Ser Met Cys Ser Tyr Leu Arg His Arg Pro Glu Gly Arg Ser Ser Asn
595 600 605
Ile Leu Glu Ser Arg Val Thr Glu Ser Pro Thr Ser Ala Arg Thr Ala
610 615 620
Ala Ser Ala Arg Ser Pro Met Ala Pro Thr Ser Ala Phe Leu Thr Ala
625 630 635 640
Leu Val Leu Leu Ser Cys Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu
645 650 655
Pro Gln Thr His Ser Leu Ala His Thr Arg Ala Leu Arg Leu Leu Ala
660 665 670
Gln Met Arg Arg Ile Ser Pro Phe Ser Cys Leu Asp His Arg Arg Asp
675 680 685
Phe Gly Phe Pro Gln Glu Ala Leu Gly Gly Asn Gln Val Gln Lys Ala
690 695 700
Gln Ala Met Ala Leu Val His Glu Met Leu Gln Gln Thr Phe Gln Leu
705 710 715 720
Phe Ser Thr Glu Gly Ser Ala Ala Ala Trp Asp Glu Ser Leu Leu His
725 730 735
Gln Phe Cys Thr Gly Leu Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys
740 745 750
Val Met Gln Glu Ala Gly Leu Glu Gly Thr Pro Leu Leu Glu Glu Asp
755 760 765
Ser Ile Leu Ala Val Arg Lys Tyr Phe His Arg Leu Thr Leu Tyr Leu
770 775 780
Gln Glu Lys Ser Tyr Ser Pro Cys Ala Trp Glu Ile Val Arg Ala Glu
785 790 795 800
Val Met Arg Ala Phe Ser Ser Ser Thr Asn Leu Gln Asp Arg Leu Arg
805 810 815
Arg Lys Glu Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Met Tyr Lys
820 825 830
Met Gln Leu Leu Cys Cys Ile Ala Leu Thr Leu Ala Leu Met Ala Asn
835 840 845
Gly Ala Pro Thr Ser Ser Ser Thr Lys Asn Thr Lys Lys Gln Leu Glu
850 855 860
Pro Leu Leu Leu Asp Leu Gln Leu Leu Leu Lys Glu Val Lys Asn Tyr
865 870 875 880
Glu Asn Ala Asp Leu Ser Arg Met Leu Thr Phe Lys Phe Tyr Met Pro
885 890 895
Lys Gln Ala Thr Glu Leu Lys His Leu Gln Cys Leu Val Glu Glu Leu
900 905 910
Lys Ala Leu Glu Gly Val Leu Asn Leu Gly Gln Ser Lys Asn Ser Asp
915 920 925
Ser Ala Asn Ile Lys Glu Ser Met Asn Asn Ile Asn Val Thr Val Leu
930 935 940
Glu Leu Lys Gly Ser Glu Thr Ser Phe Lys Cys Glu Tyr Asp Asp Glu
945 950 955 960
Thr Val Thr Ala Val Glu Phe Leu Asn Lys Trp Ile Thr Phe Cys Gln
965 970 975
Ser Ile Tyr Ser Thr Leu Thr
980
<210> 2
<211> 2949
<212> DNA
<213>Genome 1
<400> 2
gatacataca agagtgaaat tgctcatcgg tttaaagatt tgggagaaca atatttcaaa 60
ggcctagtgc tgattgcctt ttctcagcat ctccagcaat gcccatatga agagcatgtg 120
aaattagtga gggaagtaac tgagtttgca aaaacatgtg ttgctgatga gtcagctgaa 180
aattgtgaca agtcaattca cactctcttt ggagataaat tatgtgcaat tccatccctt 240
cgtgaacact atggtgactt ggctgactgc tgtgaaaaag aagagcctga gagaaacgaa 300
tgcttcctcc aacacaaaaa tgataacccc gacatcccta aattgaaacc agaccctgtt 360
gctttatgcg ctgacttcca ggaagatgaa cagaagtttt ggggaaaata cctatatgaa 420
attgccagaa gacatcccta tttctacgcc ccagaactcc tttattatgc cattatatat 480
aaagatgttt tttcagaatg ctgccaagct gctgataaag ctgcctgcct gttaccaaag 540
attgagcatc tgagagaaaa agtactgact tccgccgcca aacagagact taagtgtgcc 600
agtatccaaa aattcggaga gagagctttc aaagcatggt cattagctcg cctgagccag 660
agatttccca aggctgactt tacagagatt tccaagatag tgacagatct tgcaaaagtc 720
cacaaggaat gctgccatgg tgacctgctt gaatgtgcag atgacagggc ggatcttgcc 780
aaatatatat gtgaaaatca agacacaatc tccactaaac tgaaggaatg ctgtgataag 840
cctctgttgg aaaaatccca ctgcattgct gaggcaaaaa gagatgaatt gcctgcagac 900
ctgaacccat tagaacatga ttttgttgaa gataaggaag tttgtaaaaa ctataaagaa 960
gcaaagcatg tcttcctggg cacgtttttg tatgagtatt caagaaggca cccagactac 1020
tctgtctcat tgctgctgag aattgccaag atatatgaag ccacactgga ggactgctgt 1080
gccaaagagg atcctccggc atgctatgcc acagtgtttg ataaatttca gcctcttgtg 1140
gatgagccta agaatttaat caaacaaaac tgtgaacttt ttgaaaaact tggagagtat 1200
ggattccaaa atgcgctcat agttcgttac accaagaaag taccccaagt gtcaactcca 1260
actcttgtgg aggtcgcaag aaaactagga ctagtgggct ctaggtgttg taagcgtcct 1320
gaagaagaaa gactgtcctg tgctgaagac tatctgtccc tggtcctgaa ccggttgtgc 1380
gtgttgcacg agaagacacc agtgagcgaa aaagttacca aatgctgcac agagtccttg 1440
gtgaacagac ggccttgctt ttctgctctg acaccagacg aaacatacaa acccaaagaa 1500
tttgttgagg gaaccttcac cttccatgca gacctatgca cacttcctga ggatgagaaa 1560
caaatcaaga agcaaactgc actcgttgag ttgttgaaac acaagcctca tgcaacagag 1620
gaacaactga gaactgtcct gggcaacttt gcagcctttg tacaaaagtg ctgcgccgct 1680
cctgaccatg aggcctgctt tgctgtggag ggtccgaaat ttgttattga aattcgaggg 1740
atcttagccg gtggtggtgg ttctggtggt ggtggttcta tgtgttccta tttaagacac 1800
aggcctgagg gaaggtcttc aaacatccta gagagcaggg tcacagagtc acccacctca 1860
gccaggacag cagcatctgc aaggtcccca atggccccaa cctcagcctt cctcacggcc 1920
ctggtgctgc tcagctgcaa tgccatctgc tctctgggct gcgacctgcc tcagacccac 1980
agcctggctc acaccagggc cctgaggctc ctggcacaaa tgaggagaat ctcccccttc 2040
tcctgcctgg accacagaag ggactttgga ttcccccaag aggccttggg gggcaaccag 2100
gtccagaagg ctcaagccat ggctctggtg catgagatgc tccagcagac cttccagctc 2160
ttcagcacag agggctcggc tgctgcctgg gatgagagcc tcctgcacca gttctgcact 2220
ggactggatc agcagctcag ggacctggaa gcctgtgtca tgcaggaggc cgggctggaa 2280
gggacccccc tgctggagga ggactccatc ctggctgtga ggaaatactt ccacagactc 2340
accctctatc tgcaagagaa gagctacagc ccctgtgcct gggagatcgt cagggcagaa 2400
gtcatgagag ccttctcttc ctccacaaac ctgcaagaca gactcaggag gaaggagggt 2460
ggtggtggtt ctggtggtgg tggttctatg tataagatgc agctcttgtg ttgcattgca 2520
ctaacccttg cactcatggc aaacggtgca cctacttcaa gctctacaaa gaacacaaag 2580
aaacaactgg agccattgct gctggattta cagttgcttt tgaaggaagt taagaattac 2640
gagaatgctg atctctccag gatgctcaca tttaaatttt acatgcccaa gcaggctaca 2700
gaattgaaac accttcagtg tttagtagaa gaactcaaag ctctggaggg agtgctaaat 2760
ttaggtcaaa gcaaaaactc tgactcagca aatatcaagg aatcaatgaa caatatcaac 2820
gtaacagttt tggaactaaa gggatctgaa acaagtttca aatgtgaata tgatgatgag 2880
acagtaactg ctgttgaatt tctgaacaaa tggattacct tttgtcaaag catctactca 2940
acactgact 2949
<210> 3
<211> 2949
<212> DNA
<213>Genome 2
<400> 3
gacacctaca aatctgaaat cgctcaccgt ttcaaagacc tgggtgaaca gtacttcaaa 60
ggtctggttc tgatcgcttt ctctcagcac ctgcagcagt gcccgtacga agaacacgtt 120
aaactggttc gtgaagttac cgaattcgct aaaacctgcg ttgctgacga atctgctgaa 180
aactgcgaca aatctatcca caccctgttc ggtgacaaac tgtgcgctat cccgtctctg 240
cgtgaacact acggtgacct ggctgactgc tgcgaaaaag aagaaccgga acgtaacgaa 300
tgcttcctgc agcacaaaaa cgacaacccg gacatcccga aactgaaacc ggacccggtt 360
gctctgtgcg ctgacttcca ggaagacgaa cagaaattct ggggtaaata cctgtacgaa 420
atcgctcgtc gtcacccgta cttctacgct ccggaactgc tgtactacgc tatcatctac 480
aaagacgttt tctctgaatg ctgccaggct gctgacaaag ctgcttgcct gctgccgaaa 540
atcgaacacc tgcgtgaaaa agttctgacc tctgctgcta aacagcgtct gaaatgcgct 600
tctatccaga aattcggtga acgtgctttc aaagcttggt ctctggctcg tctgtcgcag 660
aggttcccga aagctgactt caccgaaatc tctaaaatcg ttaccgacct ggctaaagtt 720
cacaaagaat gctgccacgg tgacctgctg gaatgcgctg acgaccgtgc tgacctggct 780
aaatacatct gcgaaaacca ggacaccatc tctaccaaac tgaaagaatg ctgcgacaaa 840
ccgctgctgg aaaaatctca ctgcatcgct gaagctaaac gtgacgaact gccggctgac 900
ctgaacccgc tggaacacga cttcgttgaa gataaggaag tgtgcaaaaa ctacaaagaa 960
gctaaacacg ttttcctggg taccttcctg tacgaatact ctcgtcgtca cccggactac 1020
tctgtttctc tgctgctgcg tatcgctaaa atctacgaag ctaccctgga agactgctgc 1080
gctaaagaag acccgccggc ttgctacgct accgttttcg acaaattcca gccgctggtt 1140
gacgaaccga aaaacctgat caaacagaac tgcgaactgt tcgaaaaact gggtgaatac 1200
ggtttccaga acgctctgat cgttcgttac accaaaaaag ttccgcaggt ttctaccccg 1260
accctggttg aagttgctcg taaactgggt ctggttggtt ctcgttgctg caaacgtccg 1320
gaagaagaac gtctgtcttg cgctgaagac tacctgtctc tggttctgaa ccgtctgtgc 1380
gttctgcacg aaaaaacccc ggtttctgaa aaagttacca aatgctgcac cgaatctctg 1440
gttaaccgtc gtccgtgctt ctctgctctg accccggacg aaacctacaa accgaaagaa 1500
ttcgttgaag gtaccttcac cttccacgct gacctgtgca ccctgccgga agacgaaaaa 1560
cagatcaaaa aacagaccgc tctggttgaa ctgctgaaac acaaaccgca cgctaccgaa 1620
gaacagctgc gtaccgttct gggtaacttc gctgctttcg ttcagaaatg ctgcgctgct 1680
ccggaccacg aagcttgctt cgctgttgaa ggtccgaaat tcgttatcga aatccgtggt 1740
atcctggctg gtggtggtgg ttctggtggt ggtggttcta tgtgctctta cctgcgtcac 1800
cgtccggaag gtcgttcttc taacatcctg gaatctcgtg ttaccgaatc tccgacctct 1860
gctcgtaccg ctgcttctgc tcgttctccg atggctccga cctctgcttt cctgaccgct 1920
ctggttctgc tgtcttgcaa cgctatctgc tctctgggtt gcgacctgcc gcagacccac 1980
tctctggctc acacccgtgc tctgcgtctg ctggctcaga tgcgtcgtat ctctccgttc 2040
tcttgcctgg accaccgtcg tgacttcggt ttcccgcagg aagctctggg tggtaaccag 2100
gttcagaaag ctcaggctat ggctctggtt cacgaaatgc tgcagcagac cttccagctg 2160
ttctctaccg aaggttctgc tgctgcttgg gacgaatctc tgctgcacca gttctgcacc 2220
ggtctggacc agcagctgcg tgacctggaa gcttgcgtta tgcaggaagc tggtctggaa 2280
ggtaccccgc tgctggaaga agactctatc ctggctgttc gtaaatactt ccaccgtctg 2340
accctgtacc tgcaggaaaa atcttactct ccgtgcgctt gggaaatcgt tcgtgctgaa 2400
gttatgcgtg ctttctcttc ttctaccaac ctgcaggacc gtctgcgtcg taaagaaggt 2460
ggtggtggtt ctggtggtgg tggttctatg tacaaaatgc agctgctgtg ctgcatcgct 2520
ctgaccctgg ctctgatggc taacggtgct ccgacctctt cttctaccaa aaacaccaaa 2580
aaacagctgg aaccgctgct gctggacctg cagctgctgc tgaaagaagt taaaaactac 2640
gaaaacgctg acctgtctcg tatgctgacc ttcaaattct acatgccgaa acaggctacc 2700
gaactgaaac acctgcagtg cctggttgaa gaactgaaag ctctggaagg tgttctgaac 2760
ctgggtcagt ctaaaaactc tgactctgct aacatcaaag aatctatgaa caacatcaac 2820
gttaccgttc tggaactgaa aggctcggaa accagcttca aatgcgaata cgacgacgaa 2880
accgttaccg ctgttgaatt cctgaacaaa tggatcacct tctgccagtc tatctactct 2940
accctgacc 2949
<210> 4
<211> 1749
<212> DNA
<213>Pig albumin gene sequence before optimizing
<400> 4
gatacataca agagtgaaat tgctcatcgg tttaaagatt tgggagaaca atatttcaaa 60
ggcctagtgc tgattgcctt ttctcagcat ctccagcaat gcccatatga agagcatgtg 120
aaattagtga gggaagtaac tgagtttgca aaaacatgtg ttgctgatga gtcagctgaa 180
aattgtgaca agtcaattca cactctcttt ggagataaat tatgtgcaat tccatccctt 240
cgtgaacact atggtgactt ggctgactgc tgtgaaaaag aagagcctga gagaaacgaa 300
tgcttcctcc aacacaaaaa tgataacccc gacatcccta aattgaaacc agaccctgtt 360
gctttatgcg ctgacttcca ggaagatgaa cagaagtttt ggggaaaata cctatatgaa 420
attgccagaa gacatcccta tttctacgcc ccagaactcc tttattatgc cattatatat 480
aaagatgttt tttcagaatg ctgccaagct gctgataaag ctgcctgcct gttaccaaag 540
attgagcatc tgagagaaaa agtactgact tccgccgcca aacagagact taagtgtgcc 600
agtatccaaa aattcggaga gagagctttc aaagcatggt cattagctcg cctgagccag 660
agatttccca aggctgactt tacagagatt tccaagatag tgacagatct tgcaaaagtc 720
cacaaggaat gctgccatgg tgacctgctt gaatgtgcag atgacagggc ggatcttgcc 780
aaatatatat gtgaaaatca agacacaatc tccactaaac tgaaggaatg ctgtgataag 840
cctctgttgg aaaaatccca ctgcattgct gaggcaaaaa gagatgaatt gcctgcagac 900
ctgaacccat tagaacatga ttttgttgaa gataaggaag tttgtaaaaa ctataaagaa 960
gcaaagcatg tcttcctggg cacgtttttg tatgagtatt caagaaggca cccagactac 1020
tctgtctcat tgctgctgag aattgccaag atatatgaag ccacactgga ggactgctgt 1080
gccaaagagg atcctccggc atgctatgcc acagtgtttg ataaatttca gcctcttgtg 1140
gatgagccta agaatttaat caaacaaaac tgtgaacttt ttgaaaaact tggagagtat 1200
ggattccaaa atgcgctcat agttcgttac accaagaaag taccccaagt gtcaactcca 1260
actcttgtgg aggtcgcaag aaaactagga ctagtgggct ctaggtgttg taagcgtcct 1320
gaagaagaaa gactgtcctg tgctgaagac tatctgtccc tggtcctgaa ccggttgtgc 1380
gtgttgcacg agaagacacc agtgagcgaa aaagttacca aatgctgcac agagtccttg 1440
gtgaacagac ggccttgctt ttctgctctg acaccagacg aaacatacaa acccaaagaa 1500
tttgttgagg gaaccttcac cttccatgca gacctatgca cacttcctga ggatgagaaa 1560
caaatcaaga agcaaactgc actcgttgag ttgttgaaac acaagcctca tgcaacagag 1620
gaacaactga gaactgtcct gggcaacttt gcagcctttg tacaaaagtg ctgcgccgct 1680
cctgaccatg aggcctgctt tgctgtggag ggtccgaaat ttgttattga aattcgaggg 1740
atcttagcc 1749
<210> 5
<211> 678
<212> DNA
<213>Pig IFN-α gene order before optimizing
<400> 5
atgtgttcct atttaagaca caggcctgag ggaaggtctt caaacatcct agagagcagg 60
gtcacagagt cacccacctc agccaggaca gcagcatctg caaggtcccc aatggcccca 120
acctcagcct tcctcacggc cctggtgctg ctcagctgca atgccatctg ctctctgggc 180
tgcgacctgc ctcagaccca cagcctggct cacaccaggg ccctgaggct cctggcacaa 240
atgaggagaa tctccccctt ctcctgcctg gaccacagaa gggactttgg attcccccaa 300
gaggccttgg ggggcaacca ggtccagaag gctcaagcca tggctctggt gcatgagatg 360
ctccagcaga ccttccagct cttcagcaca gagggctcgg ctgctgcctg ggatgagagc 420
ctcctgcacc agttctgcac tggactggat cagcagctca gggacctgga agcctgtgtc 480
atgcaggagg ccgggctgga agggaccccc ctgctggagg aggactccat cctggctgtg 540
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 600
tgggagatcg tcagggcaga agtcatgaga gccttctctt cctccacaaa cctgcaagac 660
agactcagga ggaaggag 678
<210> 6
<211> 462
<212> DNA
<213>Pig IL-2 gene order before optimizing
<400> 6
atgtataaga tgcagctctt gtgttgcatt gcactaaccc ttgcactcat ggcaaacggt 60
gcacctactt caagctctac aaagaacaca aagaaacaac tggagccatt gctgctggat 120
ttacagttgc ttttgaagga agttaagaat tacgagaatg ctgatctctc caggatgctc 180
acatttaaat tttacatgcc caagcaggct acagaattga aacaccttca gtgtttagta 240
gaagaactca aagctctgga gggagtgcta aatttaggtc aaagcaaaaa ctctgactca 300
gcaaatatca aggaatcaat gaacaatatc aacgtaacag ttttggaact aaagggatct 360
gaaacaagtt tcaaatgtga atatgatgat gagacagtaa ctgctgttga atttctgaac 420
aaatggatta ccttttgtca aagcatctac tcaacactga ct 462
<210> 7
<211> 1749
<212> DNA
<213>Pig albumin gene sequence after optimization
<400> 7
gacacctaca aatctgaaat cgctcaccgt ttcaaagacc tgggtgaaca gtacttcaaa 60
ggtctggttc tgatcgcttt ctctcagcac ctgcagcagt gcccgtacga agaacacgtt 120
aaactggttc gtgaagttac cgaattcgct aaaacctgcg ttgctgacga atctgctgaa 180
aactgcgaca aatctatcca caccctgttc ggtgacaaac tgtgcgctat cccgtctctg 240
cgtgaacact acggtgacct ggctgactgc tgcgaaaaag aagaaccgga acgtaacgaa 300
tgcttcctgc agcacaaaaa cgacaacccg gacatcccga aactgaaacc ggacccggtt 360
gctctgtgcg ctgacttcca ggaagacgaa cagaaattct ggggtaaata cctgtacgaa 420
atcgctcgtc gtcacccgta cttctacgct ccggaactgc tgtactacgc tatcatctac 480
aaagacgttt tctctgaatg ctgccaggct gctgacaaag ctgcttgcct gctgccgaaa 540
atcgaacacc tgcgtgaaaa agttctgacc tctgctgcta aacagcgtct gaaatgcgct 600
tctatccaga aattcggtga acgtgctttc aaagcttggt ctctggctcg tctgtcgcag 660
aggttcccga aagctgactt caccgaaatc tctaaaatcg ttaccgacct ggctaaagtt 720
cacaaagaat gctgccacgg tgacctgctg gaatgcgctg acgaccgtgc tgacctggct 780
aaatacatct gcgaaaacca ggacaccatc tctaccaaac tgaaagaatg ctgcgacaaa 840
ccgctgctgg aaaaatctca ctgcatcgct gaagctaaac gtgacgaact gccggctgac 900
ctgaacccgc tggaacacga cttcgttgaa gataaggaag tgtgcaaaaa ctacaaagaa 960
gctaaacacg ttttcctggg taccttcctg tacgaatact ctcgtcgtca cccggactac 1020
tctgtttctc tgctgctgcg tatcgctaaa atctacgaag ctaccctgga agactgctgc 1080
gctaaagaag acccgccggc ttgctacgct accgttttcg acaaattcca gccgctggtt 1140
gacgaaccga aaaacctgat caaacagaac tgcgaactgt tcgaaaaact gggtgaatac 1200
ggtttccaga acgctctgat cgttcgttac accaaaaaag ttccgcaggt ttctaccccg 1260
accctggttg aagttgctcg taaactgggt ctggttggtt ctcgttgctg caaacgtccg 1320
gaagaagaac gtctgtcttg cgctgaagac tacctgtctc tggttctgaa ccgtctgtgc 1380
gttctgcacg aaaaaacccc ggtttctgaa aaagttacca aatgctgcac cgaatctctg 1440
gttaaccgtc gtccgtgctt ctctgctctg accccggacg aaacctacaa accgaaagaa 1500
ttcgttgaag gtaccttcac cttccacgct gacctgtgca ccctgccgga agacgaaaaa 1560
cagatcaaaa aacagaccgc tctggttgaa ctgctgaaac acaaaccgca cgctaccgaa 1620
gaacagctgc gtaccgttct gggtaacttc gctgctttcg ttcagaaatg ctgcgctgct 1680
ccggaccacg aagcttgctt cgctgttgaa ggtccgaaat tcgttatcga aatccgtggt 1740
atcctggct 1749
<210> 8
<211> 678
<212> DNA
<213>Pig IFN-α gene order after optimization
<400> 8
atgtgctctt acctgcgtca ccgtccggaa ggtcgttctt ctaacatcct ggaatctcgt 60
gttaccgaat ctccgacctc tgctcgtacc gctgcttctg ctcgttctcc gatggctccg 120
acctctgctt tcctgaccgc tctggttctg ctgtcttgca acgctatctg ctctctgggt 180
tgcgacctgc cgcagaccca ctctctggct cacacccgtg ctctgcgtct gctggctcag 240
atgcgtcgta tctctccgtt ctcttgcctg gaccaccgtc gtgacttcgg tttcccgcag 300
gaagctctgg gtggtaacca ggttcagaaa gctcaggcta tggctctggt tcacgaaatg 360
ctgcagcaga ccttccagct gttctctacc gaaggttctg ctgctgcttg ggacgaatct 420
ctgctgcacc agttctgcac cggtctggac cagcagctgc gtgacctgga agcttgcgtt 480
atgcaggaag ctggtctgga aggtaccccg ctgctggaag aagactctat cctggctgtt 540
cgtaaatact tccaccgtct gaccctgtac ctgcaggaaa aatcttactc tccgtgcgct 600
tgggaaatcg ttcgtgctga agttatgcgt gctttctctt cttctaccaa cctgcaggac 660
cgtctgcgtc gtaaagaa 678
<210> 9
<211> 462
<212> DNA
<213>Pig IL-2 gene order after optimization
<400> 9
atgtacaaaa tgcagctgct gtgctgcatc gctctgaccc tggctctgat ggctaacggt 60
gctccgacct cttcttctac caaaaacacc aaaaaacagc tggaaccgct gctgctggac 120
ctgcagctgc tgctgaaaga agttaaaaac tacgaaaacg ctgacctgtc tcgtatgctg 180
accttcaaat tctacatgcc gaaacaggct accgaactga aacacctgca gtgcctggtt 240
gaagaactga aagctctgga aggtgttctg aacctgggtc agtctaaaaa ctctgactct 300
gctaacatca aagaatctat gaacaacatc aacgttaccg ttctggaact gaaaggctcg 360
gaaaccagct tcaaatgcga atacgacgac gaaaccgtta ccgctgttga attcctgaac 420
aaatggatca ccttctgcca gtctatctac tctaccctga cc 462

Claims (10)

1. pig albumin-interferon-' alpha '-interleukin-22 fusion protein, it is characterised in that:The amino acid sequence table of the fusion protein As shown in 400 < of SEQUENCE LISTING, 1 >, it is denoted as fusion protein 1.
2. a kind of gene for encoding pig albumin-interferon-' alpha '-interleukin-22 fusion protein as described in claim 1, feature It is, the nucleotides sequence list of the gene is denoted as genome 1 as shown in 400 < of SEQUENCE LISTING, 2 >;Or such as Shown in 400 < of SEQUENCE LISTING, 3 >, it is denoted as genome 2.
3. containing the expression vector of gene as claimed in claim 2.
4. containing the genetic engineering bacterium of gene as claimed in claim 2.
5. the preparation method of pig albumin-interferon-' alpha '-interleukin-22 fusion protein described in claim 1, which is characterized in that institute Preparation method is stated to include the following steps:Nucleotides sequence list gene as shown in 400 < of SEQUENCE LISTING, 2 > will be contained The expression vector of group 1 or nucleotides sequence list genome 2 as shown in 400 < of SEQUENCE LISTING, 3 > imported into large intestine bar In bacterium host cell, genetic engineering bacterium is obtained, genetic engineering bacterium obtains the crude product of the fusion protein after IPTG inducing expression, Fusion protein can be obtained after purified.
6. preparation method according to claim 5, which is characterized in that the genetic engineering bacterium is pET-32a/rAlb-IFN α-IL2, preparation method are:
(1), design primer, by reverse transcription obtain or manually be respectively synthesized connect flexible linker sequence pig albumin, The target gene of porcine interferon alpha and pig interleukin 2 and 6;It is by flexible linker that pig albumin, porcine interferon alpha, pig is white thin The target gene of born of the same parents' interleukin 2 connects, the nucleotides sequence list of the target gene after connection such as SEQUENCE LISTING Shown in 400 <, 2 > or as shown in 400 < of SEQUENCE LISTING, 3 >;
(2), the target gene after connection is connected on pET-32a plasmid and obtains expression vector;
(3), expression vector is imported into e. coli host cell, genetic engineering bacterium pET-32a/rAlb-IFN can be obtained α-IL2。
7. preparation method according to claim 5 or 6, which is characterized in that the e. coli host cell is BL21 (DE3) competent cell or BL21 (DE3) competent cell with pGro7 plasmid.
8. preparation method according to claim 5, which is characterized in that the method for the purifying is:The crude product of fusion protein Successively through affinity chromatography, anion-exchange chromatography and molecular sieve chromatography purification.
9. a boar long-acting interferon, which is characterized in that the pig long-acting interferon by fusion protein described in claim 1 with It is freeze-dried to form after freeze drying protectant mixture.
10. pig long-acting interferon according to claim 9, which is characterized in that the freeze drying protectant is glycerol, mannitol And sucrose.
CN201810751030.4A 2017-08-09 2018-07-10 Pig albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon Pending CN108840945A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2017106768352 2017-08-09
CN201710676835.2A CN107383205A (en) 2017-08-09 2017-08-09 Pig albumin interferon-' alpha ' interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon

Publications (1)

Publication Number Publication Date
CN108840945A true CN108840945A (en) 2018-11-20

Family

ID=60345189

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201710676835.2A Pending CN107383205A (en) 2017-08-09 2017-08-09 Pig albumin interferon-' alpha ' interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon
CN201810751030.4A Pending CN108840945A (en) 2017-08-09 2018-07-10 Pig albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201710676835.2A Pending CN107383205A (en) 2017-08-09 2017-08-09 Pig albumin interferon-' alpha ' interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon

Country Status (1)

Country Link
CN (2) CN107383205A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114539426A (en) * 2022-03-02 2022-05-27 山东仙普爱瑞科技股份有限公司 Fusion protein containing interferon alpha, recombinant strain expressing fusion protein and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113845599B (en) * 2021-11-01 2023-09-19 长春萤火虫生物科技有限公司 Recombinant porcine interferon fusion protein and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080095141A (en) * 2007-04-23 2008-10-28 포항공과대학교 산학협력단 A fusion polypeptide comprising a human fc including human albumin linker and a biologically active polypeptide and a method of preparing the same
CN101570757A (en) * 2009-02-18 2009-11-04 河南省动物疫病预防控制中心 Porcine alpha interferon and interleukin 2 chimeric gene, construction method and protein purification method thereof
CN102757502A (en) * 2011-04-27 2012-10-31 中国医学科学院病原生物学研究所 Fused human interleukin 28B and preparation method thereof
CN105884901A (en) * 2014-10-11 2016-08-24 北京美福源生物医药科技有限公司 Recombinant human serum albumin/pancreatic glucagon peptide fusion protein having blood sugar content continuous control function
CN106282216A (en) * 2016-08-29 2017-01-04 芜湖英特菲尔生物制品产业研究院有限公司 A kind of preparation method of recombinant long-acting chicken interferon α

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080095141A (en) * 2007-04-23 2008-10-28 포항공과대학교 산학협력단 A fusion polypeptide comprising a human fc including human albumin linker and a biologically active polypeptide and a method of preparing the same
CN101570757A (en) * 2009-02-18 2009-11-04 河南省动物疫病预防控制中心 Porcine alpha interferon and interleukin 2 chimeric gene, construction method and protein purification method thereof
CN102757502A (en) * 2011-04-27 2012-10-31 中国医学科学院病原生物学研究所 Fused human interleukin 28B and preparation method thereof
CN105884901A (en) * 2014-10-11 2016-08-24 北京美福源生物医药科技有限公司 Recombinant human serum albumin/pancreatic glucagon peptide fusion protein having blood sugar content continuous control function
CN106282216A (en) * 2016-08-29 2017-01-04 芜湖英特菲尔生物制品产业研究院有限公司 A kind of preparation method of recombinant long-acting chicken interferon α

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JIN ZHAO ET AL.: ""Albumin Fusion of Interleukin-28B: Production and Characterization of Its Biological Activities and Protein Stability"", 《PLOS ONE》 *
KASER T ET AL.: ""interleukin-2 precursor [Sus scrofa],Accession NO:NP_999026.1"", 《GENBANK》 *
SANG, Y ET AL.: ""interferon-alpha-8 [Sus scrofa] ,Accession NO:ACV42397.1"", 《GENBANK》 *
YAMAUCHI K ET AL.: ""serum albumin precursor [Sus scrofa] , Accession NO:NP_001005208.1"", 《GENBANK》 *
亓振国 等: "大肠杆菌分子伴侣表达的辅助载体构建及应用", 《农业生物技术学报》 *
姚静 等: "《药物冻干制剂技术的设计与应用》", 30 June 2007, 中国医药科技出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114539426A (en) * 2022-03-02 2022-05-27 山东仙普爱瑞科技股份有限公司 Fusion protein containing interferon alpha, recombinant strain expressing fusion protein and preparation method thereof
CN114539426B (en) * 2022-03-02 2023-07-07 山东仙普爱瑞科技股份有限公司 Fusion protein containing interferon alpha, recombinant strain expressing fusion protein and preparation method of recombinant strain

Also Published As

Publication number Publication date
CN107383205A (en) 2017-11-24

Similar Documents

Publication Publication Date Title
CN108840951A (en) A kind of fusion protein and preparation method thereof being made of pig albumin, Porcine interferon-gamma and porcine interferon alpha
CN108840947A (en) Bovine albumin-interferon-&#39; alpha &#39;-interleukin-22 fusion protein, preparation method and its encoding gene, a kind of ox long-acting interferon
CN108840946A (en) Dog albumin-interferon-&#39; alpha &#39;-interleukin-22 fusion protein, preparation method and its encoding gene, a kind of dog long-acting interferon
CN108840952A (en) A kind of fusion protein and preparation method thereof being made of Chicken Albumin, chicken interferon gamma and chicken interferon α
CN108840945A (en) Pig albumin-interferon-&#39; alpha &#39;-interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon
CN108822220A (en) Sheep albumin-interferon-tau-interleukin-22 fusion protein, preparation method and its encoding gene, a kind of sheep long-acting interferon
CN108840950A (en) A kind of fusion protein and preparation method thereof being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha
CN108864302A (en) A kind of fusion protein and preparation method thereof being made of pig albumin, Porcine interferon-gamma and pig interleukin 2 and 6
CN108794644A (en) A kind of fusion protein and preparation method thereof being made of cattle interleukins-2 2, Bov IFN γ and Bov IFN α
CN108864295A (en) A kind of recombinant bovine long-acting interferon and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108864300A (en) Chicken Albumin-interferon-&#39; alpha &#39;-interleukin-22 fusion protein, preparation method and its encoding gene, a breeder long-acting interferon
CN108864298A (en) A kind of canine recombinant long-acting interferon and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108822221A (en) A kind of fusion protein and preparation method thereof being made of Chicken Albumin, chicken interferon gamma and recombinant chIL-2
CN108794645A (en) A kind of fusion protein and preparation method thereof being made of bovine albumin, Bov IFN γ and Bov IFN α
CN108840934A (en) A kind of recombination sheep long-acting interferon τ and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108840953A (en) A kind of fusion protein and preparation method thereof being made of sheep interleukin 2, sheep interferon gamma and sheep interferon-tau
CN108840941A (en) A kind of fusion protein and preparation method thereof for recombinating sheep long-acting interferon γ and preparing this long-acting interferon γ
CN108864293A (en) A kind of fusion protein being made of dog albumin and dog interferon γ and preparation method thereof and a kind of canine recombinant long-acting interferon γ
CN108840935A (en) A kind of fusion protein being made of sheep albumin and sheep interferon gamma and preparation method thereof and a kind of recombination sheep long-acting interferon γ
CN108840942A (en) A kind of Recombinant Swine long-acting interferon and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108864306A (en) A kind of fusion protein and preparation method thereof being made of canine leucocyte interleukin 2, dog interferon γ and dog interferon alpha
CN108840936A (en) A kind of Recombinant Swine long-acting interferon α and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN109053897A (en) A kind of fusion protein and preparation method thereof being made of recombinant chIL-2, chicken interferon gamma and chicken interferon α
CN108864296A (en) A kind of recombination sheep long-acting interferon and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108864301A (en) A kind of fusion protein and preparation method thereof being made of bovine albumin, Bov IFN γ and cattle interleukins-2 2

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181120